Laboratory of Neural Plasticity, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen 2200, Denmark.
Laboratory for Molecular Pharmacology, Department of Biomedical Science and Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen 2200, Denmark.
ACS Chem Neurosci. 2020 May 6;11(9):1270-1282. doi: 10.1021/acschemneuro.9b00685. Epub 2020 Apr 27.
Vascular endothelial growth factor B (VEGFB) is a pleiotropic trophic factor, which in contrast to the closely related VEGFA is known to have a limited effect on angiogenesis. VEGFB improves survival in various tissues including the nervous system, where the effect was observed mainly for peripheral neurons. The neurotrophic effect of VEGFB on central nervous system neurons has been less investigated. Here we demonstrated that VEGFB promotes neurite outgrowth from primary cerebellar granule, hippocampal, and retinal neurons . VEGFB protected hippocampal and retinal neurons from both oxidative stress and glutamate-induced neuronal death. The VEGF receptor 1 (VEGFR1) is required for VEGFB-induced neurotrophic and neuroprotective effects. Using a structure-based approach, we designed short peptides, termed Vefin1-7, mimicking the binding interface of VEGFB to VEGFR1. Vefins were analyzed for their secondary structure and binding to VEGF receptors and compared with previously described peptides derived from VEGFA, another ligand of VEGFR1. We show that Vefins have neurotrophic and neuroprotective effects on primary hippocampal, cerebellar granule, and retinal neurons with potencies comparable to VEGFB. Similar to VEGFB, Vefins were not mitogenic for MCF-7 cancer cells. Furthermore, one of the peptides, Vefin7, even dose-dependently inhibited the proliferation of MCF-7 cells . Unraveling the neurotrophic and neuroprotective potentials of VEGFB, the only nonangiogenic factor of the VEGF family, is promising for the development of neuroprotective peptide-based therapies.
血管内皮生长因子 B(VEGFB)是一种多功能的营养因子,与密切相关的 VEGFA 不同,它对血管生成的影响有限。VEGFB 可改善多种组织(包括神经系统)的存活率,其作用主要观察到在外周神经元。VEGFB 对中枢神经系统神经元的神经营养作用研究较少。在这里,我们证明 VEGFB 促进原代小脑颗粒、海马和视网膜神经元的突起生长。VEGFB 可保护海马和视网膜神经元免受氧化应激和谷氨酸诱导的神经元死亡。VEGF 受体 1(VEGFR1)是 VEGFB 诱导的神经营养和神经保护作用所必需的。我们采用基于结构的方法设计了短肽,称为 Vefin1-7,模拟 VEGFB 与 VEGFR1 的结合界面。分析了 Vefin 的二级结构及其与 VEGF 受体的结合,并与先前描述的源自另一种 VEGFR1 配体 VEGFA 的肽进行了比较。我们表明,Vefin 对原代海马、小脑颗粒和视网膜神经元具有神经营养和神经保护作用,其效力与 VEGFB 相当。与 VEGFB 相似,Vefin 对 MCF-7 癌细胞没有有丝分裂原作用。此外,其中一种肽,Vefin7,甚至呈剂量依赖性地抑制 MCF-7 细胞的增殖。揭示 VEGFB 的神经营养和神经保护潜力,VEGF 家族中唯一的非血管生成因子,有望开发基于神经营养肽的治疗方法。